<p><strong>Summary: </strong></p><p>This week on The Genetics Podcast, Patrick is joined by Lisa Gurry, Chief Business Officer of GeneDx. They discuss her path from two decades at Microsoft to leading one of the most influential genomics companies, GeneDx’s mission to deliver the fastest rare disease diagnoses, and how large-scale data, newborn screening, and AI are shaping the future of precision medicine.</p><p><strong>Show Notes: </strong></p><p><strong>0:00 </strong>Intro to The Genetics Podcast</p><p><strong>01:00</strong> Welcome to Lisa and her career path leading to joining GeneDx  </p><p><strong>03:27</strong> The core components of GeneDx and how they drive early rare disease diagnosis</p><p><strong>06:18 </strong>Insights from early genomic newborn screening pilots</p><p><strong>11:37 </strong>The clinical impact and economic benefits of newborn genomic screening</p><p><strong>14:27 </strong>How GeneDx combines data, AI, and clinical expertise to improve genomic interpretation</p><p><strong>17:44 </strong>A vision for a lifelong genomic passport and how it could guide care across every stage of life</p><p><strong>20:42 </strong>How GeneDx Infinity is unlocking new therapeutic possibilities in genetically linked autism</p><p><strong>22:48 </strong>How advocacy communities guide patient identification and connect families to opportunities</p><p><strong>26:00 </strong>Lessons from 23 years at Microsoft that Lisa now applies to leading GeneDx</p><p><strong>30:39 </strong>How Truveta emerged from the COVID crisis to build a shared-data platform for population-scale health insights</p><p><strong>32:13 </strong>What excites Lisa most about leading GeneDx and where she sees the biggest opportunities ahead</p><p><strong>34:59 </strong>Closing remarks</p><p>Please consider rating and reviewing us on your chosen podcast listening platform! </p><p><a href="https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link"><u>https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link</u></a><br></p>

The Genetics Podcast

Sano Genetics

EP 217: Building a genomic passport for every family: Insights from tech leader and rare disease parent Lisa Gurry of GeneDx

DEC 11, 202533 MIN
The Genetics Podcast

EP 217: Building a genomic passport for every family: Insights from tech leader and rare disease parent Lisa Gurry of GeneDx

DEC 11, 202533 MIN

Description

<p><strong>Summary: </strong></p><p>This week on The Genetics Podcast, Patrick is joined by Lisa Gurry, Chief Business Officer of GeneDx. They discuss her path from two decades at Microsoft to leading one of the most influential genomics companies, GeneDx’s mission to deliver the fastest rare disease diagnoses, and how large-scale data, newborn screening, and AI are shaping the future of precision medicine.</p><p><strong>Show Notes: </strong></p><p><strong>0:00 </strong>Intro to The Genetics Podcast</p><p><strong>01:00</strong> Welcome to Lisa and her career path leading to joining GeneDx  </p><p><strong>03:27</strong> The core components of GeneDx and how they drive early rare disease diagnosis</p><p><strong>06:18 </strong>Insights from early genomic newborn screening pilots</p><p><strong>11:37 </strong>The clinical impact and economic benefits of newborn genomic screening</p><p><strong>14:27 </strong>How GeneDx combines data, AI, and clinical expertise to improve genomic interpretation</p><p><strong>17:44 </strong>A vision for a lifelong genomic passport and how it could guide care across every stage of life</p><p><strong>20:42 </strong>How GeneDx Infinity is unlocking new therapeutic possibilities in genetically linked autism</p><p><strong>22:48 </strong>How advocacy communities guide patient identification and connect families to opportunities</p><p><strong>26:00 </strong>Lessons from 23 years at Microsoft that Lisa now applies to leading GeneDx</p><p><strong>30:39 </strong>How Truveta emerged from the COVID crisis to build a shared-data platform for population-scale health insights</p><p><strong>32:13 </strong>What excites Lisa most about leading GeneDx and where she sees the biggest opportunities ahead</p><p><strong>34:59 </strong>Closing remarks</p><p>Please consider rating and reviewing us on your chosen podcast listening platform! </p><p><a href="https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link"><u>https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link</u></a><br></p>